Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XYOSTED (AUTOINJECTOR) | Antares Pharma | N-209863 RX | 2018-09-28 | 3 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
androgel | New Drug Application | 2024-09-18 |
aveed | New Drug Application | 2021-08-28 |
axiron | New Drug Application | 2013-11-12 |
azmiro | New Drug Application | 2025-01-03 |
depo-testosterone | ANDA | 2024-01-11 |
jatenzo | New Drug Application | 2023-08-15 |
kyzatrex | New Drug Application | 2023-10-26 |
natesto | New Drug Application | 2022-12-19 |
striant | New Drug Application | 2009-11-19 |
testim | New Drug Application | 2021-08-25 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Testosterone Cypionate, Testosterone Cypionate, Slayback Pharma Llc | |||
11311554 | 2039-03-25 | DP | |
11642355 | 2039-03-25 | DP | |
Testosterone Enanthate, Xyosted (Autoinjector), Antares Pharma Inc | |||
10646495 | 2038-08-30 | DP | |
9950125 | 2036-09-04 | DP | U-2418 |
9744302 | 2035-11-19 | DP | |
11191908 | 2035-10-18 | DP | |
11813435 | 2035-02-25 | DP | |
10238662 | 2035-02-19 | DP | U-2418 |
10912782 | 2035-02-19 | DP | U-2418 |
11160751 | 2034-10-07 | DP | U-2418 |
10881798 | 2034-02-11 | DP | |
10821072 | 2033-06-04 | DP | U-2418 |
11844804 | 2033-06-04 | U-2418 | |
10357609 | 2031-08-21 | DP | |
10905827 | 2031-08-21 | DP | |
11446440 | 2031-08-21 | DP | |
10279131 | 2031-07-31 | DP | |
11497753 | 2030-03-19 | DP | |
8021335 | 2026-10-04 | DP | |
8562564 | 2026-01-24 | DP | |
9180259 | 2026-01-24 | DP | |
9533102 | 2026-01-24 | DP | |
9629959 | 2026-01-24 | DP | |
10478560 | 2026-01-24 | DP | |
11446441 | 2026-01-24 | DP | |
Testosterone, Natesto, Acerus | |||
11090312 | 2034-03-17 | U-1616 | |
8574622 | 2024-02-04 | DP | |
8784869 | 2024-02-04 | DP | |
8784882 | 2024-02-04 | DP | U-1557 |
8877230 | 2024-02-04 | U-1616 | |
Testosterone, Vogelxo, Upsher Smith Labs | |||
8785426 | 2034-02-11 | DP | U-1531 |
9295675 | 2034-02-11 | DP | U-1531 |
9662340 | 2034-02-11 | DP | U-1531 |
Testosterone, Axiron, Eli Lilly And Co | |||
8435944 | 2027-09-27 | U-1390 | |
8419307 | 2027-02-26 | U-1386 | |
8807861 | 2027-02-26 | DP | U-1563 |
9289586 | 2027-02-26 | U-1390 | |
8993520 | 2026-06-02 | U-1390 | |
9180194 | 2026-06-02 | U-1390 | |
Testosterone, Androgel, Besins Hlthcare | |||
8466136 | 2026-10-12 | DP | |
8466137 | 2026-10-12 | U-1103 | |
8466138 | 2026-10-12 | U-1103 | |
8486925 | 2026-10-12 | DP | |
8729057 | 2026-10-12 | DP | |
8741881 | 2026-10-12 | U-1103 | |
8754070 | 2026-10-12 | DP | |
8759329 | 2026-10-12 | DP |
Code | Description |
---|---|
J3121 | Injection, testosterone enanthate, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | — | 1 |
Drug common name | Testosterone enanthate |
INN | testosterone |
Description | Testosterone enanthate is a heptanoate ester and a sterol ester. It has a role as an androgen. It is functionally related to a testosterone. |
Classification | Small molecule |
Drug class | steroids (androgens, anabolics); antiandrogens |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C |
PDB | — |
CAS-ID | 315-37-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1200335 |
ChEBI ID | 9464 |
PubChem CID | 9416 |
DrugBank | DB00624 |
UNII ID | 3XMK78S47O (ChemIDplus, GSRS) |